Anzeige
Mehr »
Mittwoch, 02.07.2025 - Börsentäglich über 12.000 News
Nächster Kursturbo?: 226 % Plus seit Januar - wie weit kann diese Aktie noch steigen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
275 Leser
Artikel bewerten:
(1)

UV Concepts: UV-Concepts Announces Exclusive Agreement with Hytech Ireland to Distribute UV-C Enclosure (UVE) Across Ireland and the United Kingdom

First and Only Digitally-Connected Automated "No Touch" UV Light Solution Designed to Improve the Cleaning and Disinfecting of Portable Medical Equipment

High UV-C Dose Provides Reliable Pathogen Kill in 60 Seconds

ENGLEWOOD, Colo., and DUBLIN, July 21, 2020 (GLOBE NEWSWIRE) -- UV-Concepts Inc., an infection control and prevention company, announced today that it has signed an exclusive agreement with Hytech Ireland to distribute across Ireland and the United Kingdom the Company's UV-C Enclosure (UVE), the first and only digitally-connected automated no-touch UV-C enclosure purpose-built for large portable medical equipment designed to improve manual cleaning and disinfecting.

Ultraviolet germicidal irradiation (UVGI) is a disinfection method that uses short-wavelength ultraviolet light (UV-C) to kill or inactivate microorganisms. Healthcare-associated infections (HAI's) are a growing concern worldwide, and evidence shows that high-touch surfaces on portable medical equipment such as wheelchairs, stretchers, and infusion pumps are a potential vector for transmission of bacteria and viruses.

"The concern for cleaning and disinfecting high-touch surfaces in the healthcare environment has grown exponentially due to COVID-19," said Jeremy Starkweather, President & Co-Founder, UV-Concepts Inc. "We're very pleased to partner with Hytech Ireland and make the UVE available for healthcare institutions globally to help protect patients, healthcare workers, and visitors from harmful bacteria and viruses."

Prior to the COVID-19 pandemic, the Centers for Disease Control and Prevention (CDC) estimate about 700,000 patients are diagnosed with an HAI each year in the United States, and of those, 70,000 die during their acute care hospitalization. While progress has been made to reduce and, in some cases, eliminate HAIs, the market is constantly seeking new and improved disinfection solutions.

"We were impressed with the broad clinical applications of the easy-to-use UVE," said Rodney Cadden, microbiologist and Founder and Chief Executive Officer of Hytech Ireland. "Our partnership with UV-Concepts allows us to offer this product to the infection control healthcare community, as well as other early adopter sectors such as the hospitality and leisure industries that can benefit from the product's differentiated use and modality."

About UVE
The UVE is an automated no-touch UV-C enclosure purpose-built for large portable medical equipment and is digitally-connected to real-time equipment indicator tags and a cloud-based platform to ensure protocol adherence. The UVE is designed to optimize the key principles of UV-C light disinfection effectiveness (intensity, proximity, and line of sight) by surrounding items inside of a fully-enclosed, highly-reflective space. This produces a high UV-C dose in 60 seconds for a controlled environment leading to consistent results. The UVE is registered with the Environmental Protection Agency (EPA, Product Registration No. 92890-DV-1).

About UV-Concepts, Inc.
UV-Concepts, an infection control and prevention company, is focused on collaborating with healthcare institutions willing to challenge existing paradigms with regards to the cleaning and disinfecting of portable medical equipment. For more information, please visit www.uvconcepts.com (http://www.uvconcepts.com).

About Hytech Ireland
Hytech Ireland was formed in June 2016 to control healthcare-associated infections in Irish private and public health systems as well as cross-contamination in other industries. Working with buying influences in Europe, Middle East and Australia, Hytech offers sustainable route to market in different continents on UV device applications. Hytech offers both passive and reactive technologies, along with a full team to validate the efficacy in UK/ IRE.

For more information, please visit www.hytech.ie (http://www.hytech.ie).

U.S. Media Contact:
Erich Sandoval
FINN Partners
Tel: +1-917-497-2867
E-mail: erich.sandoval@finnpartners.com (mailto:erich.sandoval@finnpartners.com)

Ex-U.S. Contact:
Rodney Cadden, CEO
Hytech
Tel: 353 (0)86 3828054
E-mail: rodney@hytech.ie

© 2020 GlobeNewswire (Europe)
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.